The golden hour of prehospital reperfusion with triple antiplatelet therapy: A sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy-Reference-Cited by-同舟云学术

The golden hour of prehospital reperfusion with triple antiplatelet therapy: A sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy

Published:2010-12 Issue:6 Volume:160 Page:1079-1084
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Heestermans Ton,van 't Hof Arnoud W.J.,ten Berg Jurriën M.,van Werkum Jochem W.,Boersma Eric,Mosterd Arend,Stella Pieter R.,van Zoelen Arthur B.,Gosselink A.T. Marcel,Kochman Waclav,Dill Thorsten,Koopmans Petra C.,van Houwelingen Gert,Zijlstra Felix,Hamm Christian

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Antman;J Am Coll Cardiol,2008

2. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial;Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators;Lancet,2006

3. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction;Zijlstra;J Am Coll Cardiol,2002

4. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review;Vlaar;Circulation,2008

5. Facilitated PCI in patients with ST-elevation myocardial infarction;Ellis;N Engl J Med,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction;Biomedicines;2024-09-04

2. Prehospital tirofiban increases the rate of disrupted myocardial infarction in patients with ST-segment elevation myocardial infarction: insights from the On-TIME 2 trial;European Heart Journal: Acute Cardiovascular Care;2024-06-07

3. Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarction;Expert Opinion on Drug Metabolism & Toxicology;2023-10-03

4. Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction – A post hoc analysis of the cel-02 phase IIa study;American Heart Journal;2023-08

5. Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials;Heliyon;2023-05